Morning Hubsters!
This is Chris, on for Wire Wednesday.
What’s going on out there? A quick reminder that Friday is the deadline for your rockstar women dealmakers in private equity nominations. Send nominations to me and/or questions at christopher.w@pei.group.
Here's the news line-up for today:
- Blackstone makes its first investment in Japan’s fintech sector
- MidOcean invests in Re-Sourcing Group
- Allied Industrial Partners moving from deal-by-deal to its debut fund
First time
Blackstone Group is making its first investment in Japan’s fintech sector, with its acquisition of a majority stake in Sony Payment Services from Sony Bank, writes Obey Martin Manayiti on PE Hub.
Upgrade to the premium version of the Wire to learn all about the strategy.
Recruiting
MidOcean Partners made a significant investment in the Re-Sourcing Group. Read more here on PE Hub.
Funded
Independent sponsor Allied Industrial Partners, formed in 2019, has hit the market with its debut fund. Check out this story and our extensive database of new managers here.
Awards
It’s that time again! We’ve opened our annual Deal of the Year awards for the best exits of 2023. Deadline is Friday, Feb. 16.
Winners are chosen in seven categories: Deal of the Year, Large-Market Deal of the Year, Middle Market Deal of the Year, Small Market Deal of the Year, Turnaround of the Year, International Deal of the Year and Secondaries Deal of the Year.
Visit here for contest rules and other information, including lists of past winners. And hit me up with questions at christopher.w@pei.group (but please read the rules PDF that can be downloaded, which should answer most of your questions).
That’s it for me! Have a great rest of your Wednesday. Hit me up with tips n’ gossip, feedback and book recommendations at christopher.w@pei.group or find me on LinkedIn.
Read the full wire commentary on PE Hub ...
Correction: In yesterday's Wire, we said that Inceptua includes 340B among its services. We should have said that its distribution services include access (also known as expanded access, compassionate use, named patient supply) to allow patients to use medicines prior to them being commercially available.